John D. Hosley

Studies of Aβ Pharmacodynamics in the Brain, Cerebrospinal Fluid, and Plasma in Young (Plaque-Free) Tg2576 Mice Using the γ-Secretase Inhibitor N2-[(2 S)-2-(3,5-Difluorophenyl)-2-hydroxyethanoyl]-N1-[(7 S)-5-methyl-6-oxo-6,7-dihydro-5 H-dibenzo[b,d]azepin-7-yl]-L-alaninamide (LY-411575)

Thomas A. Lanz, John D. Hosley, Wade J. Adams et al. · Journal of Pharmacology and Experimental Therapeutics · 2004 · 131 citations

Targeting Delavirdine/Atevirdine Resistant HIV-1:  Identification of (Alkylamino)piperidine-Containing Bis(heteroaryl)piperazines as Broad Spectrum HIV-1 Reverse Transcriptase Inhibitors

Donna L. Romero, Robert A. Olmsted, Toni J. Poel et al. · Journal of Medicinal Chemistry · 1996 · 57 citations · Full text

(−)-6-Chloro-2-[(1-furo[2,3-<i>c</i>]pyridin-5-ylethyl)thio]-4-pyrimidinamine, PNU-142721, a New Broad Spectrum HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitor

Donn G. Wishka, David R. Graber, Laurice A. Kopta et al. · Journal of Medicinal Chemistry · 1998 · 48 citations · Full text

Immunodeficiencies, Immunology, Altmetric Attention Score +20

Predicting oral absorption of drugs: a case study with a novel class of antimicrobial agents.

Allen R. Hilgers, Donald Smith, John J. Biermacher et al. · Pharmaceutical Research · 2003 · 41 citations

Antimicrobial Drug Discovery, Antimicrobial Susceptibility, Antibiotics +13